Our Process

Multi-omic Data
Generating patient-derived clinical metadata and biospecimen samples

AI
Predicting viable biomarkers and therapeutic candidates

Synthetic Biology
Production of small molecules via cell-free expression

Functional Screening
High throughput immune-profiling assays
We are using proprietary methods in genomic sequencing, artificial intelligence, and synthetic biology to discover biomarkers and novel therapeutics for the most challenging immunologic disorders.
Team

Dora Yu, PhD
Scientist
Advisors
Supported By

Partners

Contact Us
LOCATION
280 Utah Ave. South San Francisco, CA
PHONE
(650) 479-5539
info@pragmabio.com